DAFNA CAPITAL MANAGEMENT LLC – NGM Biopharmaceuticals, Inc. Transaction History
DAFNA CAPITAL MANAGEMENT LLC portfolio value:
$980,000
portfolio value
DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+2.03%
quarter
NGM Biopharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -30.38% | -32.7K shares | -400K | $13.08 | 74.95K |
Q2 2022 | share | 0.00% | 0 shares | -262K | $12.82 | 107.65K | |
Q1 2022 | share | Increase | +33.76% | 27.16K shares | 217K | $15.25 | 107.65K |
Q4 2021 | share | Increase | +22.91% | 15K shares | 49K | $17.56 | 80.48K |
Q3 2021 | share | Increase | +114.69% | 34.98K shares | 775K | $21.02 | 65.48K |
Q2 2021 | share | Increase | +205.02% | 20.50K shares | 310K | $19.72 | 30.50K |
Q1 2021 | share | Increase | 0.00% | 10K shares | 291K | $29.07 | 10K |
Q3 2019 | share | Decrease | -100.00% | -6.26K shares | -92K | $13.85 | 0 |
Q2 2019 | share | Increase | 0.00% | 6.26K shares | 92K | $14.64 | 6.26K |